Sex-specific association of fetuin-a with type 2 diabetes in older community-dwelling adults: The Rancho Bernardo study

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1994-2000

  Laughlin, Gail A ^a   Barrett Connor, Elizabeth ^a   Cummins, Kevin M ^a   Daniels, Lori B ^a,b   Wassel, Christina L ^a   Ix, Joachim H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A; GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE;

EID: 84886034132     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1870     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
2. DECODE Study Group. Age- and sexspecific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-69
3. Shaw JE, de Courten M, Boyko EJ, Zimmet PZ. Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 1999;22:762-766
4. Basu R, Dalla Man C, Campioni M, et al. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 2006;55:2001-2014
5. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006;95:136-147
6. Williams JW, Zimmet PZ, Shaw JE, et al. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med 2003;20:915-920
7. Glümer C, J ørgensen T, Borch-Johnsen K; Inter99 Study. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003;26:2335-2340
8. Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabet Med 2008;25:296-302
9. Barrett-Connor E. Factors associated with the distribution of fasting plasma glucose in an adult community. Am J Epidemiol 1980;112:518-523
10. Wingard DL. E. B-C, McPhillips JB: Community-based study of prevalence of NIDDM in older adults. Diabetes Care 1990;13:3-8
11. Rauth G, Pöschke O, Fink E, et al. The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem 1992;204:523-529
12. Laughlin GA, Cummins KM, Wassel CL, Daniels LB, Ix JH. The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo Study. J AmColl Cardiol 2012;59:1688-1696
13. Ix JH, Biggs ML, Mukamal KJ, et al. Association of fetuin-A with incident diabetes mellitus in community-living older adults: the Cardiovascular Health Study. Circulation 2012;125:2316-2322
14. Stefan N, Fritsche A, Weikert C, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008;57:2762-2767
15. Ix JH, Katz R, de Boer IH, et al. Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis. Clin Chem 2012;58:887-895
16. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and antimitogenic activity. Cell 1989;58:631-640
17. Ix JH, Wassel CL, Kanaya AM, et al.; Health ABC Study. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008;300:182-188
18. Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 2013;62:49-55
19. Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program. Prev Med 1976;5:207-215
20. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421
21. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J Am Soc Nephrol 2001;11:A0828
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
23. Ix JH, Barrett-Connor E, Wassel CL, et al. The associations of fetuin-Awith subclinical cardiovascular disease in communitydwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011;58:2372-2379
24. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 1980;111:705-712
25. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova- Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study. Insulin secretion and insulin sensitivit y pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 2003;26: 868-874
26. Pomerleau J, McKeigue PM, Chaturvedi N. Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care 1999; 22:430-433
27. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006;113: 1760-1767
28. Mori K, Emoto M, Yokoyama H, et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006;29: 468
29. Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/ fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857
30. Tönjes A, Fasshauer M, Kratzsch J, Stumvoll M, Blüher M. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One 2010;5: e13911
31. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf) 2011;75:450-455
32. Vionnet N, Hani EH, Dupont S, et al. Genomewide search for type 2 diabetessusceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000;67: 1470-1480
33. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-αged Japanese men. Diabetes Care 2007;30:2940-2944
34. Harrison TA, Hindorff LA, Kim H, et al. Family history of diabetes as a potential public health tool. Am J Prev Med 2003; 24:152-159